The cannabis legalization movement is expanding with Mexico now set to adopt a law making it legal for medical and scientific purposes.
On April 28, the Lower House of Congress approved a previously voted bill, according to the Yucatan Times, and will now go to the hands of Mexican president Enrique Peña Nieto for approval. According to Reuters, he is expected to sign it into law.
Despite the excitement surround the news, experts have said to lower expectations when it comes to drug trafficking in Mexico since the bill only refers to medical and scientific use.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 


“It won’t change anything,” Raúl Benítez Manau, an expert on security affairs at the National Autonomous University of Mexico told the AFP. “Narcotrafficking is going to stay the same.”
Mexican officials will now have to begin drafting specific instructions for medical companies to follow as they begin using cannabis in their research.

Interest from Canada

Thanks to this announcement, Aaron Salz, an advisor for Canadian companies in the cannabis sector with Stoic Advisory, said in an interview with the Investing News Network it’s now likely for some types of partnerships to develop.
“I think you will definitely see interest in Canadian companies in participating in the Mexican market,” he said. “You will definitely see interest in companies right away in exporting to the Mexican market and to aiding those companies there in getting things set up.”
However, Salz also said he doesn’t think any companies will be rushing to set up shop in Mexico, due to an uncertainty in what the licensing process may look like there.
“You’ll certainly see partnerships, you’ll see information sharing. I would almost be certain that the regulators will communicate with each other if they haven’t already,” Salz added.
Salz told the Investing News Network one of the most exciting things in the cannabis sector right now is that Canadian companies can be part of the export process for medical purposes in countries like Brazil, Australia, and Germany.
As of yet, no information regarding potential developing partnerships or interest related to Mexico’s cannabis legalization has been released, but it is more likely than those deals will begin taking some form in the coming months once the law is set in place.

Investor Takeaway

The news of legalization from a country that has a positive business relationship with Canada should excited investors in the market. The test is now to wait and see which company will launch themselves into the Mexican market.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less